Myelo Therapeutics GmbH develops innovative treatments in areas of high unmet medical needs.
Its lead compound, myelo001, is a small molecule that is effective on the hematogenesis. Its oral application is being investigated as a treatment for
- chemotherapy-induced myelosuppression (CIM), including chemotherapy-induced neutropenia (CIN), chemotherapy-induced thrombocytopenia, and chemotherapy-induced lymphocytopenia
- radiation-induced myelosuppression (RIM)
- acute radiation syndrome (ARS)
Frequently Asked Questions About Myelo Therapeutics GmbH
What does Myelo therapeutics gmbh do?+
Myelo Therapeutics GmbH develops innovative treatments in areas of high unmet medical needs. Its lead compound, myelo001, is a small molecule that is effective on the hematogenesis. Its oral application is being investigated as a treatment for - chemotherapy-induced myelosuppression (CIM), including chemotherapy-induced neutropenia (CIN), chemotherapy-induced thrombocytopenia, and chemotherapy-induced lymphocytopenia - radiation-induced myelosuppression (RIM) - acute radiation syndrome (ARS)
What is Myelo therapeutics gmbh's industry? +
Myelo therapeutics gmbh operates in the Biotechnology
industry.
What is Myelo therapeutics gmbh's revenue? +
Myelo therapeutics gmbh's revenue is 11m - 100m
What is Myelo therapeutics gmbh's company size? +
Myelo therapeutics gmbh has 11 - 50 employees.
The Go-to Sales Technology According to G2
Get Started With Clodura
Sign Up for Free
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per
month at no cost.
Revenue
Total Funding
Size
